A new project at the chair held by Prof. Müller-Terpitz aims to compare modern approaches to biological interventions at the genome and epigenome level. The project, called COMPASS-ELSI (Comparative Assessment of Genome and Epigenome Editing in Medicine: Ethical, Legal and Social Implications), will start in March 2019 and is funded with 350,000 euros over the period of two years. Prof. Müller-Terpitz receives the grant together with his colleague Prof. Eva Winkler from the National Center for Tumor Diseases (NCT), a medicine and ethics expert from Heidelberg.